Compare Definium Therapeutics Inc. Common Shares (DFTX) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs VF Corp — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.8 (market cap $4.59B), while VF Corp trades at $15.06 (market cap $5.71B). The key difference: VF Corp is the larger of the two by market cap, and VF Corp pays a 2.48% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and VF Corp for 65 Days on average.
| DFTX | VFC | |
|---|---|---|
Market Cap | $4.59B | $5.71B |
Volume | 2,103,937 | 8,987,330 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $21.55 |
52-Week Low | $10.68 | $12.62 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $3.55B | $10.00B |
Dividend Yield | — | 2.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VFC trades at $15.00, up 4.31% today, with a bullish technical signal from moving averages and oscillators. The company reported mixed quarterly results, beating in Q4 2025 but missing in subsequent quarters, with revenue declining from $11.8B in 2022 to $9.5B in 2025. Analyst consensus is a 'Hold' with a $18.33 price target, representing 22% upside potential from current levels.
VFC faces execution challenges with Vans brand weakness offsetting strength in Outdoor segments, though valuation appears attractive with P/S of 0.61. Key risks include ongoing revenue declines, negative net income, and high debt levels. The stock offers potential upside if management's turnaround plan succeeds, but requires careful monitoring of quarterly execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
